Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Boston University, School of Public Health
HIV+ children with severe pneumonia fail treatment more often than uninfected children
June 23rd, 2006
HIV+ children with severe pneumonia fail standard WHO treatment with parenteral penicillin or oral amoxicillin more often than do uninfected children. In a recently published study, investigators in the United States conducted a study to "determine whether children aged 3-59 months with mild or nonsymptomatic human immunodeficiency virus (HIV) infection and WHO-defined severe pneumonia have a higher failure rate than do HIV-uninfected children when treated with the standard WHO treatment of parenteral penicillin or oral amoxicillin. "This study was a planned sub-analysis of a randomized trial of 3-59-month-old children presenting with WHO-defined...
Source: Biotech Law Weekly (2006-06-23)
|
